Premium
Annovis Bio Inc (ANVS)
NYSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company’s lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer’s disease, as well as in open-label phase 3 to treat parkinson’s disease. It also deve... Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company’s lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer’s disease, as well as in open-label phase 3 to treat parkinson’s disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer’s disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.11 | -5.72916666667 | 1.92 | 2.065 | 1.78 | 1470923 | 1.89130722 | CS |
| 4 | -0.49 | -21.3043478261 | 2.3 | 2.4705 | 1.75 | 1342871 | 2.03365765 | CS |
| 12 | -0.73 | -28.7401574803 | 2.54 | 3.0288 | 1.5407 | 1163396 | 1.99379008 | CS |
| 26 | -2.67 | -59.5982142857 | 4.48 | 4.6399 | 1.5407 | 797430 | 2.39116133 | CS |
| 52 | -1.52 | -45.6456456456 | 3.33 | 5.5 | 1.5407 | 925583 | 2.70164116 | CS |
| 156 | -13.54 | -88.2084690554 | 15.35 | 22.49 | 1.11 | 636814 | 5.73005303 | CS |
| 260 | -70.19 | -97.4861111111 | 72 | 132 | 1.11 | 452872 | 12.3308036 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
